Sacituzumab govitecan (SG) efficacy in hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (MBC) by HER2 immunohistochemistry (IHC) status in the phase III TROPiCS-02 study Meeting Abstract
| Authors: | Schmid, P.; Cortés, J.; Marmé, F.; Rugo, H. S.; Tolaney, S. M.; Oliveira, M.; Loirat, D.; Jhaveri, K.; Yoon, O. K.; Motwani, M.; Wang, H.; Delaney, R. J.; Bardia, A. |
| Abstract Title: | Sacituzumab govitecan (SG) efficacy in hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (MBC) by HER2 immunohistochemistry (IHC) status in the phase III TROPiCS-02 study |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S635 |
| End Page: | S636 |
| Language: | English |
| ACCESSION: | WOS:000866211600210 |
| DOI: | 10.1016/j.annonc.2022.07.253 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 214MO -- Source: Wos |
